Trial intelligence / Profile preview

ATHX-105 phosphate in obesity

NCT00735683Phase 2Withdrawn

Sponsor
Healios
Start
Sep 2008
Primary completion
Apr 2009
Modality
Stem Cell Therapies
01

Overview

A Phase 2 trial of invimestrocel in obesity, sponsored by Healios. Planned start Sep 2008; status: withdrawn.

02

Drugs

invimestrocel
03

Conditions

obesity

Beyond the preview

Go deeper on NCT00735683.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00735683.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call